ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,851.70
-0.15%
S&P ASX All Technology
3,077.90
0.70%
Brent Oil
82.435
-1.31%
US Dollar vs AUD
1.50104
0.15%
Bitcoin
70,894.54
-0.78%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Palisade Bio Inc (PALI)

  7. Palisade Bio Inc (PALI) News

PALI

Palisade Bio (PALI)

Palisade Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PALI
DateTimeSourceHeadlineSymbolCompany
21/05/202422:30GlobeNewswire Inc.Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Local Bioactivation and Dose Dependent Efficacy Response in Preclinical Mouse ModelsNASDAQ:PALIPalisade Bio Inc
20/05/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PALIPalisade Bio Inc
18/05/202406:51Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PALIPalisade Bio Inc
17/05/202406:44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PALIPalisade Bio Inc
14/05/202422:05GlobeNewswire Inc.Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:PALIPalisade Bio Inc
14/05/202406:07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PALIPalisade Bio Inc
11/05/202406:52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PALIPalisade Bio Inc
11/05/202406:37Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PALIPalisade Bio Inc
11/05/202406:37Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PALIPalisade Bio Inc
09/05/202408:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PALIPalisade Bio Inc
09/05/202408:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PALIPalisade Bio Inc
09/05/202407:06Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PALIPalisade Bio Inc
07/05/202422:30GlobeNewswire Inc.Palisade Bio Appoints Margery Fischbein to its Board of DirectorsNASDAQ:PALIPalisade Bio Inc
07/05/202421:30GlobeNewswire Inc.Palisade Bio Announces Closing of $4 Million Private Placement Priced At-The- Market Under Nasdaq RulesNASDAQ:PALIPalisade Bio Inc
02/05/202422:30GlobeNewswire Inc.Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq RulesNASDAQ:PALIPalisade Bio Inc
01/05/202422:30GlobeNewswire Inc.Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)NASDAQ:PALIPalisade Bio Inc
23/04/202422:30GlobeNewswire Inc.Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine ApproachNASDAQ:PALIPalisade Bio Inc
16/04/202422:30GlobeNewswire Inc.Palisade Bio Successfully Demonstrates Bioactivation of PALI-2108 In Ex-Vivo Study of Normal Healthy and Ulcerative Colitis Patients’ StoolNASDAQ:PALIPalisade Bio Inc
11/04/202423:15GlobeNewswire Inc.Palisade Bio to Participate in the Virtual Investor Lunch Break EventNASDAQ:PALIPalisade Bio Inc
10/04/202422:15GlobeNewswire Inc.Palisade Bio Presents Development Overview of PALI-2108 at the IBD Innovate: Product Development for Crohn’s & Colitis™NASDAQ:PALIPalisade Bio Inc
04/04/202408:30GlobeNewswire Inc.Palisade Bio Announces 1-for-15 Reverse Stock SplitNASDAQ:PALIPalisade Bio Inc
27/03/202423:00GlobeNewswire Inc.Palisade Bio Reports Year End 2023 Financial Results and Provides Corporate UpdateNASDAQ:PALIPalisade Bio Inc
07/03/202408:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PALIPalisade Bio Inc
16/02/202400:35GlobeNewswire Inc.Palisade Bio to Present at Digestive Disease Week (DDW) 2024NASDAQ:PALIPalisade Bio Inc
15/02/202406:54Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PALIPalisade Bio Inc
14/02/202412:10Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PALIPalisade Bio Inc
14/02/202408:38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PALIPalisade Bio Inc
14/02/202407:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PALIPalisade Bio Inc
14/02/202407:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PALIPalisade Bio Inc
14/02/202407:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PALIPalisade Bio Inc
 Showing the most relevant articles for your search:NASDAQ:PALI

Your Recent History

NYSE
KO
Coca Cola
ASX
XAO
Australian SE All Ordina...
ASX
ORG
Origin Energy
FX
AUDJPY
AUD vs Yen
ASX
CBA
Commonwealth Bank Of Aus...
NYSE
XOM
Exxon Mobil
FTSE
UKX
FTSE 100
NASDAQ
GOOGL
Alphabet
ASX
AMP
AMP
FX
AUDUSD
AUD vs US Dollar
NYSE
NKE
Nike
ASX
XJO
S&P ASX 200
ASX
BHP
BHP
CCOM
SILVER
SILVER
SPI
SP500
S&P 500
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved